Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Alnylam Pharmaceuticals, Inc.

Pharmaceutical Preparations · Cambridge, MA, United States

  1. PrincipalsBryan SupranEVP, CLO and SecretaryJeffrey V. PoultonEVP, Chief Financial OfficerTolga TangulerEVP, Chief Commercial Officerand 4 more
  2. CompanyAlnylam Pharmaceuticals, Inc.Cambridge, MA, United States
  3. Phone line+1 (617) 551-8200General business
Request a quotealnylam.com ↗

Alnylam Pharmaceuticals, Inc. is an SEC-registered Nasdaq-listed company (ticker ALNY) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 7

Chief executive

Yvonne GreenstreetChief Executive Officer

Chair & board

Stuart A ArbuckleDirector (Board)

Finance

Jeffrey V. PoultonEVP, Chief Financial Officer

Sales & commercial

Tolga TangulerEVP, Chief Commercial Officer

Technology & engineering

Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Pushkal GargEVP Chief R&D

Legal

Bryan SupranEVP, CLO and Secretary

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Bryan Supran — EVP, CLO and Secretary

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Jeffrey V. Poulton — EVP, Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Tolga Tanguler — EVP, Chief Commercial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Yvonne Greenstreet — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers